Kera Capital Partners’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$468K Buy
1,209
+429
+55% +$159K 0.04% 337
2026
Q1
$228K Buy
+780
New +$256K 0.03% 505

Other funds holding ELV

Kera Capital Partners's ELV Position: Q2 2026 in Review

Kera Capital Partners increased its Elevance Health (ELV) stake by 55% in Q2 2026, buying an estimated $159K and bringing the position to 1,209 shares worth $468K. The position accounts for 0.04% of the portfolio, ranked #337.

Kera Capital Partners first reported a position in ELV in Q1 2026 and has held it in 2 quarters since. 1,601 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

  • Kera Capital Partners held 1,209 shares of Elevance Health worth $468K as of Q2 2026.
  • Kera Capital Partners bought 429 Elevance Health shares in Q2 2026, an estimated $159K.
  • Elevance Health made up 0.04% of Kera Capital Partners's portfolio in Q2 2026, its #337 holding.
  • Kera Capital Partners first reported a position in Elevance Health in Q1 2026 and has held it in 2 quarters since.
  • 1,601 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on Kera Capital Partners's 13F filing for Q2 2026, filed 14 Aug 2026.